Search

everythinglearnresearchcommunity

for

Search:↓

Cancer survivors need better skin care to improve their quality of life.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

A holistic approach combining lifestyle changes, stress management, exercise, and herbal medicine can effectively treat and prevent keloids.

Doctors use their experience to choose treatments for scarring hair loss because it's hard to diagnose and treat.

Drug repurposing can speed up and reduce costs in drug discovery, especially for cancer treatment.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

The data suggests that dosing differences can help manage spasticity in patients with upper motor neuron dysfunction.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Including ineffective or unsafe doses in reviews can lead to misleading conclusions about alopecia areata treatments.

Improving access to hidradenitis suppurativa care can reduce social disparities.

Combination therapy, including JAK inhibitors, effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

The study created a 27-item measure to assess the impact of skin diseases.

The document suggests changing medical education to balance generalists and specialists, focusing on patient needs.

Patients with skin diseases rated psychological effects as most impactful, needing a treatment approach that addresses both mind and body.

India is ideal for dermatology trials due to diverse patients and cost-effectiveness.

Siddha therapeutics successfully treated a 14-year-old's alopecia areata, leading to full hair regrowth without side effects.

New and repurposed treatments are improving outcomes in dermatology.

Rational design strategies are crucial for developing effective nanozymes for anti-inflammatory uses.

Combination therapy effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Risk analysis is important for safely adjusting pharmaceutical formulas while maintaining their quality and effectiveness.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Targeting hair follicles can improve skin treatments and reduce side effects.

Integrating biological networks improves drug repurposing and ADR prediction.